Cleviprex approved in US

The FDA has approved The Medicines Company’s ca channel blocker Cleviprex for the IV treatment of hypertension

Cleviprex shown to reduce and control high blood pressure in elderly patients

Cleviprex (clevidipine), produced The Medicines Company, has been shown to rapidly achieve and maintain blood pressure control in patients with acutely elevated blood pressure

Clevidipine to enter new Phase III trial for Acute Hypertension and Intracerebral Hemorrhage

A forthcoming Phase III trial of Clevidipine (Clevelox, Cleviprex) for Acute Hypertension and Intracerebral Hemorrhage is being carried out by The Medicines Company.